Supported by the Israel Innovation Authority, the study aims to speed right-ventricular assessment in suspected ...

Medical experts warn that "ghost symptoms" like back pain or mild cramping could be the only warning signs of a ...

A woman has shared her success story after finally winning a lifelong battle with her weight thanks to the help of Slimming World. For Linda Kathryn Derbyshire, 59, from Burnley, weight had been a ...

A 1000 ng/mL D-dimer threshold safely rules out pulmonary embolism in low-likelihood patients, reducing unnecessary chest imaging in emergency care.

An LMU research team led by Professor Olivia M. Merkel, Chair of Drug Delivery at LMU, has developed a new delivery system ...

Researchers at University College London (UCL) have uncovered a key mechanism that helps the body switch off inflammation—a breakthrough that could lead to new treatments for chronic diseases ...

Scientists at The Lundquist Institute for Biomedical Innovation have identified a previously unknown molecular safeguard that ...

Company expects preliminary unaudited AUCATZYL® net product revenue of approximately $24 million for the fourth quarter of 2025 and approximately $75 million for the full year of 2025Autolus anticipat ...

Over 70 percent of patients in the first-line subgroup responded to amivantamab plus chemotherapy with most responses lasting beyond 16 monthsNotable ...

Over 70 percent of patients in the first-line subgroup responded to amivantamab plus chemotherapy with most responses lasting beyond 16 months Notable responses were ...